Baseline models were also adjusted for age and baseline waist circumference, fasting glucose, triglycerides, and HDL, while change models were also adjusted for age and changes in these covariates.
The apparent heterogeneity remained similar after adjustment for the differential use of statins and other cardiovascular medicines, but these differences became less significant when other baseline covariates were also adjusted for.
The direct effects of baseline CRS on adiposity and CRS changes were also adjusted for baseline adiposity and freed, at least partially, of the cross-sectional confounding effects.
These models were also adjusted for baseline values of known PAD risk factors (age, sex, race, baseline smoking, and baseline ABI).
The analyses were adjusted for the minimisation covariates; in addition, the randomised comparisons were also adjusted for baseline REFLUX questionnaire scores and for baseline by treatment interaction.
All models were also adjusted for sex, baseline weight, and baseline steatosis.
These analyses were also adjusted for baseline score as a linear variable.
Multivariate Cox proportional hazard regressions were also adjusted for baseline Karnofsky performance score and HIV status.
Analyses were also adjusted for baseline factors associated with dropout (HbA1c, HOMA-IR, AST, and disposition index [DI]).
Analyses of week 4 and week 16 data were also adjusted for baseline values of the outcome considered.
